BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28542918)

  • 1. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.
    Esbenshade AJ; Zhao Z; Aftandilian C; Saab R; Wattier RL; Beauchemin M; Miller TP; Wilkes JJ; Kelly MJ; Fernbach A; Jeng M; Schwartz CL; Dvorak CC; Shyr Y; Moons KGM; Sulis ML; Friedman DL
    Cancer; 2017 Oct; 123(19):3781-3790. PubMed ID: 28542918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
    Zhao Z; Patel PA; Slatnick L; Sitthi-Amorn A; Bielamowicz KJ; Nunez FA; Walsh AM; Hess J; Rossoff J; Elgarten C; Myers R; Saab R; Basbous M; Mccormick M; Aftandilian C; Richards R; Nessle CN; Tribble AC; Sheth Bhutada JK; Coven SL; Runco D; Wilkes J; Gurunathan A; Guinipero T; Belsky JA; Lee K; Wong V; Malhotra M; Armstrong A; Jerkins LP; Cross SJ; Fisher L; Stein MT; Wu NL; Yi T; Orgel E; Haeusler GM; Wolf J; Demedis JM; Miller TP; Esbenshade AJ
    J Clin Oncol; 2024 Mar; 42(7):832-841. PubMed ID: 38060973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Implementation of a Risk Prediction Model for Bloodstream Infection Safely Reduces Antibiotic Usage in Febrile Pediatric Cancer Patients Without Severe Neutropenia.
    Esbenshade AJ; Zhao Z; Baird A; Holmes EA; Dulek DE; Banerjee R; Friedman DL
    J Clin Oncol; 2020 Sep; 38(27):3150-3160. PubMed ID: 32762614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.
    Esbenshade AJ; Pentima MC; Zhao Z; Shintani A; Esbenshade JC; Simpson ME; Montgomery KC; Lindell RB; Lee H; Wallace A; Garcia KL; Moons KG; Friedman DL
    Pediatr Blood Cancer; 2015 Feb; 62(2):262-268. PubMed ID: 25327666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
    Jackson K; Anderson V; Zhao Z; Kitko CL; Connelly JA; Ho RH; Banerjee R; Dulek DE; Friedman DL; Esbenshade AJ
    Cancer; 2023 May; 129(10):1591-1601. PubMed ID: 36828805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
    Alali M; Mayampurath A; Dai Y; Bartlett AH
    Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model.
    Ojha RP; Asdahl PH; Steyerberg EW; Schroeder H
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
    Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
    Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive bacterial infections in a pediatric oncology unit in a tertiary care center.
    Trehan A; Totadri S; Gautam V; Bansal D; Ray P
    Indian J Cancer; 2014; 51(4):428-31. PubMed ID: 26842149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.
    Cost CR; Stegner MM; Leonard D; Leavey P
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):206-11. PubMed ID: 23425997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India.
    Das A; Trehan A; Oberoi S; Bansal D
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27860223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Interleukin-6, Interleukin-8, and Interleukin-10 for Predicting Bacteremia in Children with Febrile Neutropenia.
    Şahbudak Bal Z; Karadaş Özdemir N; Şen S; Yılmaz Karapınar D; Azarsız E; Aydemir Ş; Vardar F
    Turk J Haematol; 2017 Aug; 34(3):254-257. PubMed ID: 28148470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach.
    Santolaya ME; Farfán MJ; De La Maza V; Cociña M; Santelices F; Alvarez AM; Avilés CL; Becker A; O'Ryan M; Román P; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Torres JP
    Pediatr Infect Dis J; 2011 Nov; 30(11):957-61. PubMed ID: 21768922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
    Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
    Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia.
    Madsen K; Rosenman M; Hui S; Breitfeld PP
    J Pediatr Hematol Oncol; 2002 May; 24(4):256-62. PubMed ID: 11972092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
    Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
    Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia.
    Hazan G; Ben-Shimol S; Fruchtman Y; Abu-Quider A; Kapelushnik J; Moser A; Falup-Pecurariu O; Greenberg D
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e275-9. PubMed ID: 24276046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
    Raad C; Behdenna A; Fuhrmann C; Conter C; Cuzzubbo D; Rasigade JP; Bertrand Y; Domenech C
    Eur J Pediatr; 2021 Sep; 180(9):2921-2930. PubMed ID: 33835249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.